Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb

Encompass Health Corporation (EHC) is demonstrating robust operational and financial performance, characterized by increasing patient volumes and expanding margins. The company reported occupancy rising to 77.7% in H1 2025 from 72.1% in 2023, alongside consistent growth in patient discharges and significant increases in revenue per visit. This strength, attributed to strategic hospital expansion and operational efficiencies, has boosted adjusted net margin from 7.7% in 2023 to 9.7% in H1 2025. EHC shares have outperformed the industry year-to-date, and the Zacks Consensus Estimate projects an 18.3% earnings rise for 2025, positioning the company for sustained growth despite trading at a premium valuation.

Analysis

Encompass Health Corporation (EHC) is demonstrating superior operational execution and financial performance, driven by strong secular tailwinds and internal efficiencies. The company has successfully translated rising demand for inpatient rehabilitation into significant top-line growth and margin expansion. Key performance indicators are robust: occupancy rates climbed from 72.1% in 2023 to 77.7% in the first half of 2025, while patient discharges grew consistently. Critically, this volume growth is paired with expanding profitability, as the adjusted net margin widened from 7.7% in 2023 to 9.7% in H1 2025, fueled by operational discipline and substantial pricing power, with revenue per visit soaring 68% in the first half of 2025. This performance has been rewarded by the market, with EHC's stock gaining 36.4% year-to-date, far outpacing the industry's 10.1% growth. While EHC's growth significantly exceeds that of peers like Universal Health Services (UHS) and Tenet Healthcare (THC), its forward price-to-earnings ratio of 22.55X reflects a premium valuation compared to the industry average of 19.59X. The positive outlook is further supported by a Zacks Consensus Estimate for an 18.3% year-over-year increase in 2025 earnings.

Key Decisions for Investors

• Given EHC's consistent execution, strong volume growth, and significant margin expansion, investors with a growth-oriented thesis may view the stock as a core holding in the healthcare services sector, despite its recent run-up.
• The stock's premium forward P/E of 22.55X versus the industry's 19.59X suggests that high expectations are already priced in, warranting caution for new investors and a focus on entry points that offer a more favorable risk-reward profile.
• Investors should monitor key operational metrics, such as occupancy rates and revenue per visit, as any deceleration could challenge the current valuation and signal a shift in the company's growth trajectory.
• EHC's outperformance relative to peers like UHS and THC could support relative value or pairs trading strategies, potentially going long EHC while shorting a slower-growing peer to capitalize on the performance divergence.